This campaign has been commissioned by an international Japanese pharmaceutical company who combat diseases with a combination of ground‐breaking technology and biology, with an extensive track record of academic collaboration. They are seeking a solution that enables connective soft tissue repair, via either structural materials or druggable targets.
Nov
28
Comments are closed.